These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1187959)

  • 21. Task-specific tolerance to d-amphetamine.
    Emmett-Oglesby MW; Spencer DG; Wood DM; Lal H
    Neuropharmacology; 1984 May; 23(5):563-8. PubMed ID: 6738825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of training dose on discrimination of compound drug-exteroceptive stimuli.
    Duncan PM
    Psychopharmacology (Berl); 1986; 90(4):543-7. PubMed ID: 3101110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of a visual reinforcer by D-amphetamine and nicotine in adult rats: relation to habituation and food restriction.
    Wright JM; Ren S; Constantin A; Clarke PBS
    Psychopharmacology (Berl); 2018 Mar; 235(3):803-814. PubMed ID: 29199358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
    Goudie AJ; Dubicki W; Leathley M
    J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcement.
    Andrews JS; Holtzman SG
    Pharmacol Biochem Behav; 1987 Jan; 26(1):167-71. PubMed ID: 3562487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward.
    Hutcheson DM; Quarta D; Halbout B; Rigal A; Valerio E; Heidbreder C
    Behav Pharmacol; 2011 Apr; 22(2):173-81. PubMed ID: 21285875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus properties of fenfluramine in an operant task: an analysis of its cue function.
    Goudie AJ
    Psychopharmacology (Berl); 1977 Jun; 53(1):97-102. PubMed ID: 407619
    [No Abstract]   [Full Text] [Related]  

  • 28. Scopolamine and amphetamine effects on discrimination: interaction with stimulus control.
    Ksir C
    Psychopharmacologia; 1975 Jul; 43(1):37-41. PubMed ID: 1161993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. d-Amphetamine and fixed-interval performance: effects of establishing the drug as a discriminative stimulus.
    Poling AD; Appel JB
    Pharmacol Biochem Behav; 1978 Oct; 9(4):473-6. PubMed ID: 733834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. d-Amphetamine discrimination established under a conditional discrimination procedure in pigeons.
    Watanabe S
    Yakubutsu Seishin Kodo; 1983 May; 3(1):45-50. PubMed ID: 6666378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of (+)-amphetamine and apomorphine on responding for a conditioned reinforcer.
    Mazurski EJ; Beninger RJ
    Psychopharmacology (Berl); 1986; 90(2):239-43. PubMed ID: 3097705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethanol-amphetamine interaction effects on spontaneous motor activity and fixed-interval responding.
    Duncan PM; Cook NJ
    Psychopharmacology (Berl); 1981; 74(3):256-9. PubMed ID: 6791234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis.
    Doty RL; Ferguson-Segall M
    Psychopharmacology (Berl); 1987; 93(1):87-93. PubMed ID: 2819927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination of stimulus duration and d-amphetamine in pigeons: a psychophysical analysis.
    Stubbs DA; Thomas JR
    Psychopharmacologia; 1974 May; 36(4):313-22. PubMed ID: 4847385
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular analyses of the effects of d-amphetamine on fixed-interval schedule performances of rats.
    McAuley F; Leslie JC
    J Exp Anal Behav; 1986 Mar; 45(2):207-19. PubMed ID: 3958666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic d-amphetamine treatment on schedule-controlled behavior.
    Harris RA; Snell D; Loh HH
    Psychopharmacology (Berl); 1979 May; 63(1):55-61. PubMed ID: 112622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of d-amphetamine on the temporal control of operant responding in rats during a preshock stimulus.
    Sanger DJ; Blackman DE
    J Exp Anal Behav; 1976 Nov; 26(3):369-78. PubMed ID: 1003072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of 2,5-dimethoxy-4-iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli.
    Hampson CL; Body S; den Boon FS; Cheung TH; Bezzina G; Langley RW; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2010 Feb; 21(1):11-20. PubMed ID: 19949322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous brightness discrimination and reversal: the effects of amphetamine administration in the two stages.
    Weiner I; Feldon J; Ben-Shahar O
    Pharmacol Biochem Behav; 1986 Nov; 25(5):939-42. PubMed ID: 3786368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulus control and the development of behavioral tolerance to daily injections of d-amphetamine in the rat.
    Rees DC; Wood RW; Laties VG
    J Pharmacol Exp Ther; 1987 Jan; 240(1):65-73. PubMed ID: 3806398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.